BLUE JET HEALTHCARE Financial Statement Analysis
|
||
|
The Revenues of BLUE JET HEALTHCARE have increased by 44.74% YoY .
The Earnings Per Share (EPS) of BLUE JET HEALTHCARE has decreased by -18.76 % YoY. |
||
BLUE JET HEALTHCARE Last 5 Annual Financial Results
[BOM: 544009|NSE : BLUEJET]
| Standalone | Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 |
|---|---|---|---|---|---|
| Revenues | ₹1,030 Cr | ₹712 Cr | ₹721 Cr | ₹683 Cr | ₹499 Cr |
| Expenses | ₹652 Cr | ₹482 Cr | ₹502 Cr | ₹434 Cr | ₹292 Cr |
| Operating Profit (Excl OI) | ₹378 Cr | ₹229 Cr | ₹219 Cr | ₹249 Cr | ₹207 Cr |
| Other Income | ₹46 Cr | ₹29 Cr | ₹24 Cr | ₹19 Cr | ₹8.61 Cr |
| Interest | ₹0.10 Cr | ₹0.16 Cr | ₹1.36 Cr | ₹3.30 Cr | ₹5.31 Cr |
| Depreciation | ₹18 Cr | ₹28 Cr | ₹25 Cr | ₹22 Cr | ₹20 Cr |
| Profit Before Tax | ₹406 Cr | ₹220 Cr | ₹217 Cr | ₹243 Cr | ₹190 Cr |
| Profit After Tax | ₹305 Cr | ₹164 Cr | ₹160 Cr | ₹182 Cr | ₹142 Cr |
| Earnings Per Share (Rs) | ₹14.29 | ₹17.59 | ₹9.44 | ₹9.23 | ₹10.47 |
| PAT Margin (%) | 26.16 | 29.63 | 23.01 | 22.20 | 26.57 |
| ROE(%) | 19.88 | 30.85 | 21.45 | 26.60 | 42.16 |
| ROCE(%) | 27.18 | 41.06 | 28.85 | 36.24 | 54.01 |
| Total Debt/Equity(x) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Key Financials |
||
| Market Cap | : | ₹ 11,262.4 Cr |
| Revenue (TTM) | : | ₹ 885.7 Cr |
| Net Profit(TTM) | : | ₹ 234.9 Cr |
| EPS (TTM) | : | ₹ 12.4 |
| P/E (TTM) | : | 47.9 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| BLUE JET HEALTHCARE | 1.9% | 1.7% | -25.1% |
| SUN PHARMACEUTICAL INDUSTRIES | -1.2% | -2.2% | 15.8% |
| DIVIS LABORATORIES | 1% | 16.3% | 39.7% |
| TORRENT PHARMACEUTICALS | 3.2% | -0.8% | 38.6% |
| CIPLA | -0.9% | 1.6% | -9.3% |
| DR REDDYS LABORATORIES | -1.7% | -0.1% | -6.5% |
| MANKIND PHARMA | -1.5% | -6.3% | -3% |
| LUPIN | -1.4% | -8.4% | 11.6% |
| ZYDUS LIFESCIENCES | -2.7% | -1.9% | 11.7% |
BLUE JET HEALTHCARE Revenues
[BOM: 544009|NSE : BLUEJET]
| Y-o-Y | 44.74 % |
| 5 Yr CAGR | 19.87 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,030 Cr | 44.74 | |
| Mar2025 | ₹712 Cr | -1.30 | |
| Mar2024 | ₹721 Cr | 5.49 | |
| Mar2023 | ₹683 Cr | 36.99 | |
| Mar2022 | ₹499 Cr | - | |
BLUE JET HEALTHCARE Operating Profit
[BOM: 544009|NSE : BLUEJET]
| Y-o-Y | 64.78 % |
| 5 Yr CAGR | 16.25 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹378 Cr | 64.78 | |
| Mar2025 | ₹229 Cr | 4.63 | |
| Mar2024 | ₹219 Cr | -12.11 | |
| Mar2023 | ₹249 Cr | 20.50 | |
| Mar2022 | ₹207 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 13.85 % |
| 5 Yr CAGR | -3.02 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2026 | 36.67% | 13.85 | |
| Mar2025 | 32.21% | 5.99 | |
| Mar2024 | 30.39% | -16.67 | |
| Mar2023 | 36.47% | -12.04 | |
| Mar2022 | 41.46% | - | |
BLUE JET HEALTHCARE Profit After Tax
[BOM: 544009|NSE : BLUEJET]
| Y-o-Y | 86.38 % |
| 5 Yr CAGR | 21.16 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2026 | ₹305 Cr | 86.38 | |
| Mar2025 | ₹164 Cr | 2.33 | |
| Mar2024 | ₹160 Cr | -11.88 | |
| Mar2023 | ₹182 Cr | 28.23 | |
| Mar2022 | ₹142 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -11.71 % |
| 5 Yr CAGR | -0.39 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2026 | 26.16 % | -11.71 | |
| Mar2025 | 29.63 % | 28.77 | |
| Mar2024 | 23.01 % | 3.65 | |
| Mar2023 | 22.2 % | -16.45 | |
| Mar2022 | 26.57 % | - | |
BLUE JET HEALTHCARE Earnings Per Share (EPS)
[BOM: 544009|NSE : BLUEJET]
| Y-o-Y | -18.76 % |
| 5 Yr CAGR | 8.09 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2026 | ₹14 | -18.76 | |
| Mar2025 | ₹18 | 86.33 | |
| Mar2024 | ₹9.44 | 2.28 | |
| Mar2023 | ₹9.23 | -11.84 | |
| Mar2022 | ₹10 | - | |
BLUE JET HEALTHCARE Return on Capital Employed (ROCE)
[BOM: 544009|NSE : BLUEJET]
| Y-o-Y | -33.80 % |
| 5 Yr CAGR | -15.77 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2026 | 27.18% | -33.80 | |
| Mar2025 | 41.06% | 42.32 | |
| Mar2024 | 28.85% | -20.39 | |
| Mar2023 | 36.24% | -32.90 | |
| Mar2022 | 54.01% | - | |
BLUE JET HEALTHCARE Share Price vs Sensex
| Current Share Price | : | ₹595.0 |
| Current MarketCap | : | ₹ 11,262.4 Cr |
| Updated EOD on | : | Aug 20,2026 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLUE JET HEALTHCARE | 1.9% |
1.7% |
-25.1% |
| SENSEX | -0.7% |
0.1% |
-3.4% |
BLUE JET HEALTHCARE related INDICES
| BSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| BSE 1000 | -0.5% | 1% | 4.5% |
| BSE HEALTHCARE | -0.6% | 0.5% | 15.7% |
| NSE Indices | 1W | 1M | 1Y |
|---|---|---|---|
| NIFTY SMALLCAP 500 | 0% | 2.1% | NA |
| NIFTY SMALLCAP 250 | -0.2% | 1.3% | 10.3% |
| NIFTY MIDSMALLCAP400 50:50 | -0.4% | 1.1% | NA |
| NIFTY 500 EQUAL WEIGHT | -0.4% | 0.9% | 8.7% |
| NIFTY MIDSMALLCAP 400 | -0.5% | 1.1% | 11.2% |
You may also like the below Video Courses
FAQ about BLUE JET HEALTHCARE Financials
How the annual revenues of BLUE JET HEALTHCARE have changed ?
The Revenues of BLUE JET HEALTHCARE have increased by 44.74% YoY .
How the Earnings per Share (EPS) of BLUE JET HEALTHCARE have changed?
The Earnings Per Share (EPS) of BLUE JET HEALTHCARE has decreased by -18.76 % YoY .
Check out Intrinsic Value of Peers of BLUE JET HEALTHCARE
Compare Stock Analytics of Peers of BLUE JET HEALTHCARE
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs TORRENT PHARMACEUTICALS LTD
CIPLA LTD vs DR REDDYS LABORATORIES LTD vs
